Showing results (91-100 of 274) with videos related to
Sort By:
Pageof 28
Proteomics|January 15, 2002
Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancerMonica Brown Jones, Henry Krutzsch, Hungjun Shu, et al.Cancer|April 22, 2005
Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinomaEllen V Stevens, Mark Raffeld, Virginia Espina, et al.Nature Reviews. Disease Primers|March 5, 2026
Ovarian cancerClare L Scott, Susana Banerjee, Florence Joly, et al.The Oncologist|August 16, 2021
Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer InstituteArjun Mittra, Abdul Rafeh Naqash, James H Murray, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2015
Effect of Renal Dysfunction on Toxicity in Three Decades of Cancer Therapy Evaluation Program-Sponsored Single-Agent Phase I StudiesJan H Beumer, Fei Ding, Hussein Tawbi, et al.Gynecologic Oncology|May 17, 2024
A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparibJoyce F Liu, Niya Xiong, Robert M Wenham, et al.Anticancer Research|November 3, 2004
Carboxyamido-triazole (CAI), a signal transduction inhibitor induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2Frank G E Perabo, Andreas Wirger, Stefan Kamp, et al.Gynecologic Oncology|June 17, 2011
Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cellsEbony Hoskins, Jaime Rodriguez-Canales, Stephen M Hewitt, et al.Journal of Vascular and Interventional Radiology : JVIR|July 27, 2013
Personalized oncology in interventional radiologyNadine Abi-Jaoudeh, Austin G Duffy, Tim F Greten, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2014
Historical controls for metastatic pancreatic cancer: benchmarks for planning and analyzing single-arm phase II trialsPhilip A Philip, Kari Chansky, Michael LeBlanc, et al.Pageof 28